Variation of second cancer risk by family history of retinoblastoma among long-term survivors

Journal of Clinical Oncology

Volumn 30, Issue 9, 2012, Pages 950-957

  Kleinerman, Ruth A ^a   Yu, Chu Ling ^a   Little, Mark P ^a   Li, Yi ^b   Abramson, David ^d   Seddon, Johanna ^c   Tucker, Margaret A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHILD; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE; GENE MUTATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RB1 GENE; RETINOBLASTOMA; RISK FACTOR; SCHOOL CHILD; SECOND CANCER; SOFT TISSUE SARCOMA; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; INFANT; MIDDLE AGED; MORTALITY; MUTATION; PROGNOSIS; RETINA TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVOR; UNITED STATES;

RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INCIDENCE; INFANT; MALE; MARYLAND; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 84860637907     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.0239     Document Type: Article

References (27)

1. Knudson AG Jr: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823, 1971
2. Dryja TP, Mukai S, Petersen R, et al: Parental origin of mutations of the retinoblastoma gene. Nature 339:556-558, 1989 (Pubitemid 19152098)
3. Little MP, Kleinerman RA, Stiller CA, et al: Analysis of retinoblastoma age incidence data using a fully stochastic cancer model. Int J Cancer 130:631-640, 2012
4. Richter S, Vandezande K, Chen N, et al: Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 72:253-269, 2003 (Pubitemid 36194237)
5. Rushlow D, Piovesan B, Zhang K, et al: Detection of mosaic RB1 mutations in families with retinoblastoma. Hum Mutat 30:842-851, 2009
6. Draper GJ, Sanders BM, Kingston JE: Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661-671, 1986 (Pubitemid 16114627)
7. Eng C, Li FP, Abramson DH, et al: Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121-1128, 1993 (Pubitemid 23212278)
8. Fletcher O, Easton D, Anderson K, et al: Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96:357-363, 2004 (Pubitemid 38401013)
9. Marees T, Moll AC, Imhof SM, et al: Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 100:1771-1779, 2008
10. Wong FL, Boice JD Jr, Abramson DH, et al: Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk. JAMA 278:1262-1267, 1997 (Pubitemid 27435614)
11. Yu CL, Tucker MA, Abramson DH, et al: Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst 101:581-591, 2009
12. Kleinerman RA, Tucker MA, Tarone RE, et al: Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 23:2272-2279, 2005 (Pubitemid 46218720)
13. Fritz AG: International Classification of Diseases for Oncology: ICD-O (ed 3). Geneva, Switzerland, World Health Organization, 2000
14. Breslow NE, Day NE: Statistical methods in cancer research: volume II-the design and analysis of cohort studies. IARC Sci Publ 82:1-406, 1987
15. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
16. Preston DL, Rubin JH, Pierce DA, et al: Epicure: User's Guide. Seattle, WA, HiroSoft International, 1993
17. Kleinerman RA, Tucker MA, Abramson DH, et al: Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 99:24-31, 2007
18. Cox CE, Hinkley DV: Theoretical Statistics. London, United Kingdom, Chapman and Hall, 1974
19. Hawkins MM, Wilson LM, Burton HS, et al: Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270-278, 1996 (Pubitemid 26073371)
20. Tucker MA, D'Angio GJ, Boice JD Jr, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987 (Pubitemid 17126781)
21. Bradford PT, Anderson WF, Purdue MP, et al: Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev 19:2401-2406, 2010
22. Kivelä T: Trilateral retinoblastoma: A metaanalysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 17:1829-1837, 1999
23. Draper GJ, Sanders BM, Brownbill PA, et al: Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. Br J Cancer 66:211-219, 1992
24. MacCarthy A, Birch JM, Draper GJ, et al: Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol 93:33-37, 2009
25. Vogel F: Genetics of retinoblastoma. Hum Genet 52:1-54, 1979
26. Houdayer C, Gauthier-Villars M, Lauge A, et al: Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. Hum Mutat 23:193-202, 2004 (Pubitemid 38200610)
27. Marees T, van Leeuwen FE, Schaapveld M, et al: Risk of third malignancies and death after a second malignancy in retinoblastoma survivors. Eur J Cancer 46:2052-2058, 2010